Kennedy Thomas Ronan
- SEC CIK
- 0001826452
No open-market purchases or sales filed in the past year.
Current role at each company
- YCBD cbdMD, Inc.CEO and CFOas of Dec 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kennedy Thomas Ronan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 (view filing) | Sep 26 | 4 days | Kennedy Thomas RonanCEO and CFO | PPurchase | +4 | $137.50 | +$550 | –41.8K after | Derivative |
| Sep 25, 2024 (view filing) | Sep 23 | 2 days | Kennedy Thomas RonanCEO and CFO | PPurchase | +143 | $161.39 | +$23.1K | –40.8K after | Derivative |
| May 5, 2023 (view filing) | May 3 | 2 days | Kennedy Thomas RonanInterim CEO and CFO | PPurchase | −5.00K | $2.10 | −$10.5K | −43.6%6.46K after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Kennedy Thomas RonanCFO & COO | PPurchase | +7.40K | $2.04 | +$15.1K | New position7.40K after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Kennedy Thomas RonanCFO & COO | PPurchase | +3.83K | $3.91 | +$15.0K | –2.30K after | Derivative |